Onward Medical N.V. (EBR:ONWD)
4.275
-0.080 (-1.84%)
May 13, 2025, 5:35 PM CET
Onward Medical Company Description
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI).
The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement.
It operates in France, Germany, the Netherlands, the United Kingdom, and Switzerland. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.
Country | Netherlands |
Founded | 2014 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 103 |
CEO | David Marver |
Contact Details
Address: Schimmelt 2 Eindhoven, NL-5611 Netherlands | |
Website | onwd.com |
Stock Details
Ticker Symbol | ONWD |
Exchange | Euronext Brussels |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | NL0015000HT4 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
David L. Marver | Chief Executive Officer and Executive Director |
Dr. Gregoire Courtine Ph.D. | Chief Scientific Officer and Director |
Amori Fraser | Senior Finance Director |
Robert W. Odell | Vice President of Operations |
Lorenzo Fanti | Vice President of Legal |
Alexandre Casteau | Head of Strategy and Corporate Development |
Mark Landman | Vice President of Sales |
Julie Crom | Director of People and Culture |